Category: Peptides Research
Research articles and educational content on peptides and longevity compounds, authored and reviewed by Dr. James, a board-certified neurosurgeon trained at Yale University, and Dr. Tom, a licensed pharmacist. All content is for research and educational purposes only.
-
Epithalon Peptide Research: What Scientists Are Discovering About This Telomere-Extending Compound
What if aging wasn’t just inevitable wear and tear โ but a process with a measurable biological clock? That question has driven researchers toward one of the most intriguing peptides in longevity science: Epithalon. In nearly two decades of studying neurological aging, few compounds have pulled my attention quite like this tetrapeptide’s relationship with the…
-
PT-141 Research: What Scientists Are Learning About This Melanocortin Receptor Agonist
The brain’s role in desire signaling has fascinated me throughout my career in neurosurgery โ but I’ll admit, when I first encountered PT-141 research, my initial reaction was skepticism. Most compounds studied in this space work peripherally. What caught my attention about bremelanotide is that it doesn’t. It works in the brain. PT-141 (bremelanotide) is…
-
Thymosin Alpha-1 Research: What Scientists Are Learning About This Immune-Modulating Peptide
One of the most intellectually humbling aspects of neurosurgery is recognizing how often the immune system determines outcomes I once attributed purely to surgical skill. Patients with similar injuries, comparable procedures โ but wildly different recoveries. Years of watching that pattern is what put Thymosin Alpha-1 research on my radar, and I haven’t found a…
-
SS-31 Peptide Research: What Scientists Are Discovering About This Mitochondria-Targeting Compound
Early in my neurosurgery career, I became obsessed with a question that textbooks couldn’t fully answer: why do some patients with similar injuries recover so differently at the cellular level? The deeper I dug, the more I found myself reading about mitochondrial dysfunction โ not as a side effect, but as a central player in…
-
LL-37 Peptide Research: What Scientists Are Discovering About the Bodyโs Built-In First Defender
Most people think of immune defense as something that kicks in after a threat is detected โ white blood cells mobilizing, inflammation rising, antibodies forming. But there’s a peptide already on the front line before any of that happens. Scientists studying LL-37 peptide research are finding that this small, 37-amino-acid molecule may be one of…
-
NAD+ and Mitochondrial Energy Research: How This Coenzyme Powers Cellular Function
Energy is the currency of biology. Every cellular process โ from protein synthesis to axonal signaling โ requires it. And at the center of how cells actually generate that energy sits a molecule that most people have heard of but few have fully appreciated: NAD+. Nicotinamide adenine dinucleotide (NAD+) isn’t a hormone or a growth…
-
BPC-157 Neuroprotection: Animal Studies and CNS Research Evidence | BLL Peptides
I’ll be honest: when I first encountered BPC-157 in the context of gut research, I didn’t immediately think neuroscience. It was a gastric pentadecapeptide โ interesting, sure, but seemingly peripheral to my primary clinical focus. Then I started reading the CNS data, and everything shifted. BPC-157’s neurological research profile is one of the more surprising…
-
Semaglutide Research: A Deep Dive Into the GLP-1 Analog That Reshaped Metabolic Science
There are compounds that appear in the literature and compounds that reshape entire fields of medicine. Semaglutide belongs to the second category. Having watched the clinical trial data emerge over several years โ from early efficacy signals to the landmark SUSTAIN and STEP trials โ I’ve been consistently impressed by the depth of the science…
-
KPV Peptide Research: The Anti-Inflammatory Tripeptide Derived From Alpha-MSH
Sometimes the most interesting science comes packaged in the smallest molecules. KPV is a three-amino-acid peptide โ just three residues: Lys-Pro-Val โ derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (ฮฑ-MSH). It’s one of those compounds that makes you realize how much biological information can be encoded in an extremely short sequence. KPV research has…
-
Retatrutide Research: The Triple Hormone Receptor Agonist Scientists Are Watching Closely
When a Phase 2 clinical trial produces results that make researchers stop and read the data twice, the scientific community pays attention. That’s what happened with Retatrutide. The numbers coming out of early trials were striking enough that the compound quickly became one of the most discussed emerging molecules in metabolic research โ and in…
